TDOC
Teladoc Health, Inc.
NYSE · USHealthcareMedical - Healthcare Information Services
$9.65+2.33%
Price as of Jul 20, 2026
TDOC financials
Teladoc Health, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.5B | $2.6B | $2.6B | $2.4B |
| Cost of revenue | $771.6M | $751.3M | $760.0M | $744.0M |
| Gross profit | $1.8B | $1.8B | $1.8B | $1.7B |
| Operating expenses | $2.0B | $2.8B | $2.1B | $15.3B |
| Operating income | -$263.0M | -$1.0B | -$248.6M | -$13.7B |
| Net income | -$200.3M | -$1.0B | -$220.4M | -$13.7B |
| EBITDA | $147.3M | $31.7M | $43.6M | -$7.5M |
| Basic EPS | $-1.14 | $-5.87 | $-1.36 | $-84.60 |
| Diluted EPS | $-1.14 | $-5.87 | $-1.34 | $-84.60 |
| Balance sheet | ||||
| Cash & equivalents | $781.1M | $1.3B | $1.1B | $918.2M |
| Total assets | $3.1B | $3.5B | $4.4B | $4.7B |
| Total liabilities | $1.7B | $2.0B | $2.1B | $2.4B |
| Stockholders’ equity | $1.4B | $1.5B | $2.3B | $2.3B |
| Total debt | $1.0B | $1.6B | $1.6B | $1.6B |
| Net debt | $259.1M | $286.3M | $468.6M | $668.7M |
| Cash flow | ||||
| Operating cash flow | $294.4M | $293.7M | $350.0M | $189.3M |
| Capital expenditure | -$8.9M | -$10.8M | -$156.3M | -$16.5M |
| Free cash flow | $285.5M | $282.9M | $193.7M | $172.8M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |